Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: Classification, morphology, clinical presentation and response to chemotherapy

Canine leukocyte cell adhesion molecules (LeuCAMs): Characterization of the CD11/CD18 family

The canine LeuCAM (CD11/CD18) family is characterized using a panel of newly developed anti-canine LeuCAM monoclonal antibodies (mAb) as well as a cross-reactive anti-human CD11b mAb. The new anti-canine LeuCAM mAb were developed by immunizing mice with purified canine CD11/CD18 antigen derived from an anti-canine CD18 affinity column. Six mAb with reactivity to the canine LeuCAM family were cloned and characterized. These 6 included a new anti-canine CD18 mAb, 2 anti-canine CD11a mAb, 2 anti-canine CD11c mAb, and a mAb which recognizes a novel canine CD11/CD18-related macrophage antigen, designated LeuCAMmac, which is described in a separate report. The cell and tissue distribution of canine LeuCAMs was found to be similar to that reported in other species with a few notable exceptions. One prominent exception was the finding that canine CD11c, in contrast to human CD11c, was much more widely distributed on dendritic cells than it was on tissue macrophages. The molecular organization of the canine LeuCAM family was also found to be similar to that reported in other species, with the possible exception of the canine CD11b alpha chain, which may exist as several different species. It is anticipated that these anti-canine LeuCAM mAb will prove useful in immunophenotypic studies of canine hemolymphatic system neoplasia.

Lymphomas in dogs. A morphologic, immunologic, and clinical study

One hundred seventy-six canine lymphomas were classified morphologically using four of the major human lymphoma classification schemes (Rappaport, Lukes-Collins, Kiel, and the Working Formulation). All 176 dogs received the same chemotherapeutic protocol. Sixty-two of these lymphomas had their immunophenotypes established by examination of cell surface markers by automated cytofluorography. Several different morphologic types of canine lymphoma were identified and these were comparable to morphologic categories in human classification schemes. Follicular and low grade lymphomas were rare. The two most common morphologic types were diffuse large cell (centroblastic) and immunoblastic. The Kiel classification appeared to be the most useful human scheme for classifying the canine lymphomas. Cytofluorographic analysis was generally straightforward, and 60 of the 62 lymphomas were placed into one of three immunophenotypic categories: 27 pan-T(LQ1)+SIg+, 21 pan-T(LQ1)-SIg+, and 12 pan-T(LQ1)+SIg-. Two of the lymphomas could not be characterized immunologically because a pre-existing or reactive non-neoplastic population of lymphocytes made interpretation of single cell suspension analysis difficult. The authors identified correlations between morphology and survival and disease-free remission; dogs with high-grade tumors generally survived the longest and had the longest remissions. No correlations were identified between high concentrations of serum lactate dehydrogenase, age, sex, or stage of disease, and morphology, immunophenotype, remission, or survival times. A significant correlation between clinical illness and survival time was documented. The median age of the dogs was nine years, no significant effect of sex on prevalence was observed, and some breeds were significantly overrepresented. Significant morphologic-immunophenotypic correlations included shorter remission and survival times for T-cell tumors than B-cell tumors, and a highly significant correlation between the pan-T(LQ1)+SIg-"T cell" phenotype and hypercalcemia.

The treatment of multicentric canine lymphoma

Canine LSA is a fatal disease if untreated, but fortunately it is also a disease that is very responsive to therapeutic intervention. It is likely that most cases seen and treated by practitioners will be managed with the currently effective drugs and with new protocols as they are developed. Other approaches, including immunotherapy and BMT, are likely to remain more in the arena of the academic institution but should be available in the referral setting for appropriate cases. Great strides have been made in the less than 30 years that canine LSA has been widely treated; it is reasonable that similar progress is to be expected in the years to come.

Lymph node cytology

In clinical practice, animals with lymphadenopathy are eminently suitable candidates for cytology sample collection by FNAB from several enlarged nodes; or, if surgical biopsies are made, imprint smears from the tissue may yield diagnostically useful information to supplement the histological findings. Cytology may reveal the lesion to be reactive, inflammatory, or neoplastic. Cytologically, reactive nodes will contain increased numbers of plasma cells, possibly with some inflammatory cells, along with the resident lymphoid population. If inflammation is present, neutrophils and macrophages also will be found and the type of inflammation may be classified. Any infectious agent such as fungal hyphae, yeasts, bacteria, and protozoa also may be demonstrated. Aspirates may be cultured directly onto blood agar plates or transported in nutrient broth for culture at a referral laboratory. In chronic dermatopathic nodes, a mixed inflammatory cell infiltrate is expected, and in pruritic skin disorders, eosinophils usually are plentiful in node aspirates. Increased numbers of eosinophils also may be found in dogs that are microfilaremic with heartworm infection. Background debris of hemosiderin and melanin pigment and other fine particles may occur in some chronic inflammatory lymphadenopathies. Metastatic lesions are identified by the presence of foreign neoplastic cells, but this diagnosis may be missed in early metastatic spread or if the aspirate is not sufficiently cellular. A cytological guide to the classification of the more common diffuse canine lymphomas is provided but full characterization of the lymphoma type may require histology and immunocytochemistry. In practice, a simple differential Romanowsky stain such as Diff Quik is suitable for most purposes. Supplementary stains using 1 per cent toluidine blue may increase the detection of mast cells. Aspirates also may be transferred into suitable media for transport to a referral diagnostic laboratory for cytocentrifugation or further tests such as electron microscopy, immunocytochemistry, flow cytometry, and culture. Although definitive diagnosis by histopathology and other tests still may be required, in many routine cases, diagnoses can be achieved expediently in clinical practice by aspiration cytology.